Central Serous Retinopathy (CSR): Symptoms, Causes, and Treatment Options
Central Serous Chorioretinopathy (CSCR): Overview and Management
Central serous chorioretinopathy (CSCR) is characterized by serous neurosensory retinal detachment due to focal leakage through the retinal pigment epithelium (RPE), typically at the macula. It predominantly affects men aged 20–50 and is strongly associated with stress and corticosteroids.
Risk Factors and Triggers
- Male sex (M:F ~6:1)
- Psychological stress / Type A personality
- Exogenous corticosteroids (oral, topical, inhaled, injected) – major iatrogenic trigger
- Endogenous cortisol elevation (Cushing's, pregnancy)
- Sleep deprivation, shift work
- Helicobacter pylori infection (association)
- Genetic variants (CFH, HTRA1, NR3C2)
Symptoms
- Central or paracentral scotoma (gray/blind spot)
- Blurred or distorted vision (metamorphopsia)
- Micropsia (objects appear smaller)
- Reduced color saturation / contrast sensitivity
- Relative hyperopic shift (farsightedness)
- Often unilateral; bilateral in ~10–15%
Diagnostic Imaging
- OCT (Optical Coherence Tomography): Serous subretinal fluid, RPE elevation, hyperreflective foci; hallmark sign
- Fundus autofluorescence (FAF): Granular hyper/hypoautofluorescence at leak sites
- Fluorescein angiography (FA): "Inkblot" or "smokestack" leakage pattern
- Indocyanine green angiography (ICGA): Choroidal hyperpermeability, dilated choroidal vessels
Natural History
- Acute: 80–90% resolve spontaneously within 3–6 months
- Recurrence: 20–50% in same or fellow eye
- Chronic CSCR (>6 months): RPE atrophy, photoreceptor loss, persistent vision impairment
Treatment
Observation (First-line for acute, good vision)
- Discontinue corticosteroids if possible
- Stress reduction, sleep optimization
- Monitor q1–3 months with OCT
Laser Photocoagulation
- Focal laser to leak point (outside fovea) – accelerates resolution; risk of scotoma if near fovea
- Subthreshold micropulse laser – safer for subfoveal leaks; less collateral damage
Photodynamic Therapy (PDT)
- Verteporfin + low-fluence laser; targets choroidal hyperpermeability
- Standard for chronic/subfoveal CSCR; may need repeat
- Risk: photosensitivity, choroidal ischemia
Medical Therapy (Investigational/Off-label)
- Mineralocorticoid receptor antagonists: Eplerenone, spironolactone – promising RCTs
- Anti-VEGF (aflibercept, ranibizumab) – limited evidence; for CNV complication
- Beta-blockers, melatonin, rifampicin – anecdotal/small studies
Lifestyle Modifications
- Stress management (CBT, mindfulness, exercise)
- Adequate sleep (7–9 hours)
- Avoid exogenous steroids (all routes) if possible
- Smoking cessation
- Limit alcohol
Key Takeaway
CSCR is often self-limited, but chronic/recurrent cases risk permanent vision loss. Early diagnosis with OCT, corticosteroid avoidance, stress management, and timely intervention (micropulse laser, PDT) preserve visual function. Collaborate with a retina specialist for personalized care.
Eye & Vision Disorders - Related Articles
- Adjusting to New Contact Lenses: A Comprehensive Guide
- DIY Glasses Adjustment: Simple Fixes for a Perfect Fit
- Multi-Focus Contact Lenses: A Comprehensive Guide for Presbyopia
- Proper Eye Drop Application: A Step-by-Step Guide
- Comprehensive Eye Exams: Understanding Your Vision Health
- Can Clothing Change Eye Color? Perception vs. Physiology
- Pinhole Glasses: A Guide to Usage and Benefits
